CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 262 filers reported holding CLOVIS ONCOLOGY INC in Q3 2017. The put-call ratio across all filers is 0.57 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $20,016,000 | +4.3% | 806,465 | +23.4% | 0.15% | +12.6% |
| Q3 2018 | $19,198,000 | -47.4% | 653,658 | -18.5% | 0.14% | -50.4% |
| Q2 2018 | $36,470,000 | +25.5% | 802,068 | +45.7% | 0.27% | +21.4% |
| Q1 2018 | $29,057,000 | -15.5% | 550,315 | +8.9% | 0.22% | -14.8% |
| Q4 2017 | $34,378,000 | -9.2% | 505,555 | +10.0% | 0.26% | -9.6% |
| Q3 2017 | $37,860,000 | +28.3% | 459,470 | +45.8% | 0.29% | +15.5% |
| Q2 2017 | $29,509,000 | +23.4% | 315,170 | -16.1% | 0.25% | +22.9% |
| Q1 2017 | $23,910,000 | +25.4% | 375,530 | -12.5% | 0.20% | +22.8% |
| Q4 2016 | $19,064,000 | +185.6% | 429,185 | +23.4% | 0.17% | +227.5% |
| Q1 2016 | $6,675,000 | – | 347,660 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 814,833 | $45,630,648,000 | 43.63% |
| EcoR1 Capital, LLC | 384,348 | $21,523,000 | 10.89% |
| Palo Alto Investors LP | 2,102,857 | $117,760,000 | 6.91% |
| NEA Management Company, LLC | 2,279,781 | $127,668,000 | 6.19% |
| Redmile Group, LLC | 721,632 | $40,411,000 | 4.40% |
| Opaleye Management Inc. | 140,000 | $7,840,000 | 3.96% |
| CLIFTON PARK CAPITAL MANAGEMENT, LLC | 790,555 | $44,271,000 | 2.63% |
| SUFFOLK CAPITAL MANAGEMENT LLC | 339,327 | $19,002,000 | 2.31% |
| PFM Health Sciences, LP | 1,725,126 | $96,607,000 | 2.26% |
| HARBOURVEST PARTNERS LLC | 51,037 | $2,858,000 | 1.50% |